- Home
- SRTS
as 02-21-2025 12:43pm EST
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | BOCA RATON |
| Market Cap: | 110.3M | IPO Year: | 2016 |
| Target Price: | $13.00 | AVG Volume (30 days): | 559.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.41 | EPS Growth: | 1266.06 |
| 52 Week Low/High: | $2.91 - $9.33 | Next Earning Date: | 02-05-2025 |
| Revenue: | $41,807,000 | Revenue Growth: | 71.31% |
| Revenue Growth (this year): | 9.09% | Revenue Growth (next year): | 22.30% |
Stock Insider Trading Activity of Sensus Healthcare Inc. (SRTS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sardano Michael | SRTS | PRESIDENT AND GENERAL COUNSEL | Feb 10 '25 | Buy | $5.95 | 1,000 | $5,950.00 | 115,839 | |
| Rampolla Javier | SRTS | CHIEF FINANCIAL OFFICER | Feb 10 '25 | Buy | $5.95 | 501 | $2,980.95 | 40,745 |
Latest Sensus Healthcare Inc. News
SRTS Breaking Stock News: Dive into SRTS Ticker-Specific Updates for Smart Investing
MT Newswires
10 days ago
Sensus Healthcare Resumes $3 Million Share Buyback Plan
Business Wire
10 days ago
Sensus Healthcare Buys Back Shares
Simply Wall St.
13 days ago
Sensus Healthcare, Inc. Just Beat Revenue By 5.6%: Here's What Analysts Think Will Happen Next
Simply Wall St.
14 days ago
Sensus Healthcare Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
GuruFocus.com
15 days ago
Sensus Healthcare Inc (SRTS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...
Zacks
16 days ago
Sensus Healthcare, Inc. (SRTS) Lags Q4 Earnings Estimates
Business Wire
16 days ago
Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results
GuruFocus.com
17 days ago
Sensus Healthcare Inc (SRTS) Q4 2024: Everything You Need To Know Ahead Of Earnings
Compare SRTS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRTS Sensus Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.